GYRE - GYRE THERAPEUTICS, INC.

7.94
-0.160   -2.015%

Share volume: 50,625
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%
$8.10
-0.16
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 46%
Dept financing 28%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.51%
1 Month
12.78%
3 Months
-4.34%
6 Months
-4.57%
1 Year
-5.48%
2 Year
-50.25%
Key data
Stock price
$7.94
P/E Ratio 
N/A
DAY RANGE
$7.86 - $8.10
EPS 
$0.05
52 WEEK RANGE
$6.57 - $11.78
52 WEEK CHANGE
-$8.10
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
96.964 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-12-2025
BETA 
1.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$54,120
AVERAGE 30 VOLUME 
$80,612
Company detail
CEO: Han Ying
Region: US
Website: www.gyretx.com
Employees: 40
IPO year: 2015
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA.

Recent news